XLCare Pharmaceuticals, Inc.
NDC labeler code: 72865
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- LevothyroxineTirosint, Tirosint Sol, Synthroid · 12 products
- AripiprazoleAbilify, Opipza, Abilify Asimtufii · 12 products
- MethylphenidateMetadate Cd, Relexxii, Methylphenidate Hydrochloride Cd · 10 products
- Hydrocodone bitartrate and acetaminophenNorco · 8 products
- QuetiapineSeroquel, Seroquel XR · 6 products
- LisinoprilZestril, Qbrelis · 6 products
- GabapentinNeurontin, Gralise, Relgaabi · 5 products
- SimvastatinZocor · 5 products
- Oxycodone and acetaminophenEndocet, Prolate, Percocet · 4 products
- MeloxicamZybic, Xifyrm, Qamzova · 4 products
- Hydromorphone hydrochlorideDilaudid · 4 products
- LevetiracetamKeppra, Spritam, Keppra XR · 4 products
- TopiramateTopamax, Qudexy XR, Trokendi XR · 4 products
- MirtazapineRemeronsoltab, Remeron · 4 products
- Venlafaxine hydrochlorideEffexor XR · 4 products
- SildenafilViagra, Vybrique, Revatio · 4 products
- TorsemideSoaanz · 4 products
- EltrombopagPromacta · 4 products
- TadalafilCialis, Tadliq, Adcirca · 4 products
- CinacalcetSensipar · 3 products
- Potassium chlorideKlor-Con, Klor-Con M, Pokonza · 3 products
- BaclofenGablofen, Lyvispah, Baclofen (Intrathecal) · 3 products
- Losartan potassiumLosortan Potassium, Cozaar, Arbli · 3 products
- OxcarbazepineTrileptal, Oxtellar XR · 3 products
- Potassium citrateUrocit-K · 3 products
- Sertraline hydrochlorideZoloft · 3 products
- Sacubitril and valsartanEntresto · 3 products
- PitavastatinZypitamag, Livalo · 3 products
- Carbidopa and levodopaCrexont, Rytary, Sinemet · 3 products
- FamotidinePepcid · 2 products
- MaravirocSelzentry · 2 products
- Dabigatran etexilatePradaxa · 2 products
- AllopurinolAloprim · 2 products
- Oxymorphone hydrochloride2 products
- IndomethacinIndocin · 2 products
- Tamsulosin hydrochloride2 products
- Benzonatate2 products
- MethocarbamolRobaxin, Atmeksi, Tanlor · 2 products
- Methadone hydrochlorideMethadone Hydrocloride Dye-Free, Sugar-Free, Unflavored, Methadose, Methadose Sugar-Free · 2 products
- Icosapent ethylVascepa · 2 products
- Oxycodone hydrochlorideOxycontin, Roxybond, Roxicodone · 2 products
- Pantoprazole sodiumProtonix I.V., Protonix Delayed-Release, Pantoprazole Sodium I.V. · 2 products
- TofacitinibXeljanz, Xeljanz XR · 2 products
- Efavirenz1 product
- MontelukastSingulair · 1 product
- FingolimodGilenya · 1 product
- Dutasteride1 product
- AbacavirZiagen · 1 product
- OMEGA-3-ACID ethyl estersOmega-3-Acid Ethyl Ester · 1 product
- GemfibrozilLopid · 1 product
- LacosamideVimpat, Motpoly XR · 1 product
- Lamivudine and zidovudineCombivir · 1 product
- Sodium oxybateLumryz, Xyrem · 1 product
- RivaroxabanXarelto · 1 product
FDA applications for these products
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| June 3, 2026 | ANDA219530 | Tofacitinib TOFACITINIB CITRATE | Macleods Pharms |
| November 5, 2025 | ANDA210523 | Sodium oxybate SODIUM OXYBATE | Ascent Pharms Inc |
| October 2, 2025 | ANDA219721 | Mirtazapine MIRTAZAPINE | Annora Pharma |
| May 14, 2025 | ANDA219332 | Rivaroxaban RIVAROXABAN | Ascent Pharms Inc |
| January 17, 2025 | ANDA206788 | Eltrombopag ELTROMBOPAG OLAMINE | Hetero Labs Ltd V |
| January 14, 2025 | ANDA218939 | Carbidopa and levodopa CARBIDOPA AND LEVODOPA | Ascent Pharms Inc |
| October 16, 2024 | ANDA213728 | Sacubitril and valsartan SACUBITRIL AND VALSARTAN | Macleods Pharms |
| April 30, 2024 | ANDA205977 | Pitavastatin PITAVASTATIN CALCIUM | Hetero Labs Ltd V |
| December 7, 2023 | ANDA216811 | Icosapent ethyl ICOSAPENT ETHYL | Ascent Pharms Inc |
| August 3, 2023 | ANDA217748 | Allopurinol ALLOPURINOL | Hetero Labs Ltd V |
| June 7, 2023 | ANDA217579 | Meloxicam MELOXICAM | Ascent Pharms Inc |
| January 18, 2023 | ANDA215259 | Levothyroxine LEVOTHYROXINE SODIUM | Ascent Pharms Inc |
| September 14, 2022 | ANDA216335 | Lacosamide LACOSAMIDE | Aspiro |
| June 16, 2022 | ANDA204316 | Quetiapine QUETIAPINE FUMARATE | Hetero Labs Ltd V |
| May 4, 2022 | ANDA214730 | Tamsulosin hydrochloride TAMSULOSIN HYDROCHLORIDE | Ascent Pharms Inc |
| February 7, 2022 | ANDA203347 | Maraviroc MARAVIROC | Hetero Labs Ltd III |
| January 11, 2022 | ANDA215939 | Oxcarbazepine OXCARBAZEPINE | Annora Pharma |
| October 15, 2021 | ANDA215689 | Famotidine FAMOTIDINE | Ascent Pharms Inc |
| October 1, 2021 | ANDA214957 | Gabapentin GABAPENTIN | Ascent Pharms Inc |
| August 26, 2021 | ANDA215414 | Topiramate TOPIRAMATE | Ascent Pharms Inc |
| May 10, 2021 | ANDA214956 | Gabapentin GABAPENTIN | Ascent Pharms Inc |
| May 3, 2021 | ANDA214790 | Sertraline hydrochloride SERTRALINE HYDROCHLORIDE | Ascent Pharms Inc |
| February 5, 2021 | ANDA214420 | Potassium citrate POTASSIUM CITRATE | Ascent Pharms Inc |
| January 13, 2021 | ANDA214603 | Gemfibrozil GEMFIBROZIL | Ascent Pharms Inc |
| December 29, 2020 | ANDA214422 | Potassium chloride POTASSIUM CHLORIDE | Ascent Pharms Inc |
| October 21, 2020 | ANDA214419 | Venlafaxine hydrochloride VENLAFAXINE HYDROCHLORIDE | Ascent Pharms Inc |
| October 9, 2020 | ANDA212378 | Baclofen BACLOFEN | Andas 5 Holding |
| October 7, 2020 | ANDA209403 | Cinacalcet CINACALCET HYDROCHLORIDE | Hetero Labs Ltd V |
| September 23, 2020 | ANDA212133 | Hydromorphone hydrochloride HYDROMORPHONE HYDROCHLORIDE | Ascent Pharms Inc |
| May 18, 2020 | ANDA207933 | Fingolimod FINGOLIMOD HYDROCHLORIDE | Hetero Labs Ltd V |
| May 6, 2020 | ANDA207961 | Dabigatran etexilate DABIGATRAN ETEXILATE MESYLATE | Hetero Labs Ltd III |
| September 3, 2019 | ANDA211009 | Methylphenidate METHYLPHENIDATE HYDROCHLORIDE | Ascent Pharms Inc |
| March 26, 2019 | ANDA209908 | Tadalafil TADALAFIL | Hetero Labs Ltd III |
| February 25, 2019 | ANDA207420 | OMEGA-3-ACID ethyl esters OMEGA-3-ACID ETHYL ESTERS | Ascent Pharms Inc |
| February 22, 2019 | ANDA211518 | Benzonatate BENZONATATE | Ascent Pharms Inc |
| January 3, 2019 | ANDA211228 | Methadone hydrochloride METHADONE HYDROCHLORIDE | Ascent Pharms Inc |
| November 7, 2018 | ANDA211487 | Hydrocodone bitartrate and acetaminophen HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Ascent Pharms Inc |
| June 11, 2018 | ANDA202659 | Sildenafil SILDENAFIL CITRATE | Hetero Labs Ltd V |
| April 27, 2018 | ANDA078886 | Efavirenz EFAVIRENZ | Hetero Labs Ltd III |
| February 2, 2018 | ANDA210175 | Oxymorphone hydrochloride OXYMORPHONE HYDROCHLORIDE | Ascent Pharms Inc |
| December 29, 2017 | ANDA210354 | Methylphenidate METHYLPHENIDATE HYDROCHLORIDE | Ascent Pharms Inc |
| August 7, 2017 | ANDA207418 | Oxycodone hydrochloride OXYCODONE HYDROCHLORIDE | Ascent Pharms Inc |
| March 22, 2017 | ANDA207419 | Oxycodone and acetaminophen OXYCODONE AND ACETAMINOPHEN | Ascent Pharms Inc |
| October 21, 2016 | ANDA206574 | Dutasteride DUTASTERIDE | Ascent Pharms Inc |
| September 22, 2015 | ANDA207416 | Methylphenidate METHYLPHENIDATE HYDROCHLORIDE | Ascent Pharms Inc |
| August 12, 2015 | ANDA203835 | Losartan potassium LOSARTAN POTASSIUM | Hetero Labs Ltd V |
| April 28, 2015 | ANDA205064 | Aripiprazole ARIPIPRAZOLE | Hetero Labs Ltd V |
| November 26, 2014 | ANDA203623 | Sildenafil SILDENAFIL CITRATE | Hetero Labs Ltd V |
| November 25, 2014 | ANDA200895 | Simvastatin SIMVASTATIN | Hetero Labs Ltd III |
| September 10, 2014 | ANDA202843 | Montelukast MONTELUKAST SODIUM | Hetero Labs Ltd V |
| September 10, 2014 | ANDA202882 | Pantoprazole sodium PANTOPRAZOLE SODIUM | Hetero Labs Ltd V |
| February 3, 2014 | ANDA203259 | Lamivudine and zidovudine LAMIVUDINE AND ZIDOVUDINE | Hetero Labs Ltd V |
| September 13, 2013 | ANDA091560 | Abacavir ABACAVIR SULFATE | Hetero Labs Ltd III |
| April 12, 2011 | ANDA091240 | Indomethacin INDOMETHACIN | Hetero Labs Ltd III |
| October 8, 2010 | ANDA090515 | Levetiracetam LEVETIRACETAM | Hetero Labs Ltd III |
| November 6, 2009 | ANDA090200 | Methocarbamol METHOCARBAMOL | Hetero Labs Ltd III |
| January 27, 2009 | ANDA079234 | Torsemide TORSEMIDE | Hetero Labs Ltd III |
| December 20, 2006 | ANDA077927 | Meloxicam MELOXICAM | Unichem |
| July 1, 2002 | ANDA075903 | Lisinopril LISINOPRIL | Annora Pharma |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
No recall of these products (by NDC code) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026